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ABSTRACT
SERUM IgG CONCENTRATIONS OF NEONATAL CALVES FED COLOSTRUM 
REPLACER SUPPLEMENTED WITH LACTOFERRIN
by
Erin C. Shea 
University o f New Hampshire, May 2007
The objective o f this experiment was to determine the effect of various levels of 
lactoferrin supplementation in colostrum replacer fed as 1 or 2 doses on apparent 
efficiency of IgG absorption, serum IgG concentrations, and intestinal development in 
neonatal Holstein bull calves. Eighty-Holstein bull calves were assigned to a 2 x 4 
factorial arrangement o f treatments in a completely randomized block design. Bull calves 
were collected at two locations, Fairchild Teaching and Research Center at the University 
of New Hampshire (n = 48) and a commercial dairy (n = 32). All calves were fed 
colostrum replacer (CR) according to manufacturer’s recommendations within 90 min of 
birth with or without lactoferrin treatment. Lactoferrin treatments were 0 (control), 0.5,
1, and 2 g/d. At 12 h of age calves were fed either a second feeding o f CR with or 
without Lf or 2 L o f milk replacer (MR) with or without Lf. Calves continued to be fed 
MR with or without L f in 12 h increments throughout the duration of study. Calves from 
the commercial dairy were removed from study at 48 h, while calves bom at the
xii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
university were removed from the study at 72 h. Blood samples were collected for IgG at 
0, 6, 12, 18, 24, and 48 h. On average, all calves attained blood serum IgG concentration 
> 10 mg/mL resulting in successful passive transfer, except for calves fed 1 dose of CR 1 
or 2 g/d of supplemental Lf. However, there was an effect on CR feeding with calves fed 
2 doses of CR having significantly higher blood serum IgG concentrations. There was no 
effect of Lf supplementation on plasma IgG and serum protein. There was a decrease in 
apparent efficiency o f absorption (AEA) of IgG when 2 doses o f CR were fed versus 1 
dose of CR. Lactoferrin supplementation resulted in a suppressing quadratic effect on 
AEA of IgG. At the sixth feeding in which calves were 60 + 2 h of age, D-xylose 
(0.5g/kg BW) was mixed with the MR with or without supplemental Lf (UNH calves) to 
determine xylose absorption by the small intestine. Blood samples were collected before 
xylose was fed at 0, and 2, 4, 6, 8, and 12 h after feeding xylose, for measurement of 
plasma glucose and xylose concentrations. Xylose means and area under the curved 
showed Lf to have a quadratic effect on xylose absorption with 0.5 and 1 g/d of 
supplemental L f having lower plasma xylose concentrations then calves fed 0 and 2 g/d 
of supplemental Lf. There was no effect of CR feeding or supplemental Lf on plasma 
glucose concentrations. This study indicates supplementing Lf to a CR has a negative 
effect on both serum IgG and xylose absorption, demonstrating supplemental Lf is not 
beneficial to the neonatal calf.
xiii
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CHAPTER I 
REVIEW OF LITERATURE
Part 1: Nutritional and Immunological needs of the Neonatal Calf 
Introduction
The first step in successful heifer management begins with the first colostrum 
feeding. High quality maternal colostrum is designed to meet the nutritional and 
immunological needs o f the neonatal calf. If high quality colostrum is not fed to the calf 
at birth, the calf will have a higher chance for morbidity and mortality. The three largest 
costs during the first three months of age are feed, labor, and medication (Quigley, 
1996b). These costs are reduced if the calf receives high quality colostrum in the first 24 
h o f life. This is due to successful passive transfer o f IgG, resulting in blood serum IgG 
concentrations >10mg/mL. Failure of passive transfer (<10mg/mL) will not only result 
in economic loss during the first 3 months but throughout the animals entire life. Calf 
weights at 60, 120, and 180 d have been positively correlated with serum 
immunoglobulins obtained by successful passive transfer (Odde, 1986). There is also a 
correlation between failure of passive transfer and a negative impact of future milk 
production and an increase in mortality among dairy cows (Porto et al., 2007).
These findings have led to research related to colostrum management and factors 
affecting IgG absorption. Products such as colostrum replacers and supplements have 
been developed that will either provide both nutritional and immunological needs of the
1
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calf or aid in increasing the quality of maternal colostrum. Although these products may 
be beneficial when high quality colostrum is unavailable, they do not consistently 
provide. Successful passive transfer (Foster, 2006). In order for improvement of these 
products to occur, there needs to be a better understanding of other components found in 
maternal colostrum and their role in intestinal development and IgG absorption. Part 1 of 
this review provides an understanding of why the neonatal calf has certain nutritional and 
immunological needs and how these needs can be met. Part 2 of this review will focus on 
the bioactive protein lactoferrin, and how its biological functions may be beneficial to the 
neonatal calf.
Placental Transfer
Placentas are classified for their morphological and structural differences. The 
bovine placenta is morphologically classified as a cotyledonary placenta, due to the 
cotyledons, which attach the placenta to the uterine wall (Senger, 1999). The placenta is 
structurally classified as a synepitheliachorial placenta because it consists of three 
maternal and three fetal membranes (Senger, 1999). It is through these morphological 
and structural characteristics that determine what substances are allowed to pass through 
the placenta from dam to fetus.
The dam and fetus have completely separate blood supplies resulting in no direct 
blood flow from one to the other (Blowey, 1999). The cotyledons, which attach the 
placenta to the uterine wall, are the site of nutrient and waste transfer between the dam 
and fetus. At this location, blood vessels grow very close together allowing for an 
exchange of nutrients from dam to fetus and waste from fetus to dam (Blowey, 1999). 
However, only small molecules are allowed to pass between the dam and fetal blood
2
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vessels (Blowey, 1999). This prevents large molecules such as Ig from reaching the 
fetus, resulting in the calf being bom hypogammaglobulinemic.
The placenta also regulates the exchange of other nutrients such as glucose and 
amino acids. Glucose and amino acids are transported across the placenta by facilitated 
diffusion using specific carrier molecules (Senger, 1999). Lipids are not able to cross 
through the placenta, which also prevents fat soluble vitamins (A, D, E) from passing to 
the fetus. This results in the neonatal calf having high nutritional needs at birth. 
Characteristics of Neonatal Calf
Immunological and nutritional needs. The metabolic adjustments necessary in the 
transition from a fetus to a neonatal calf are dramatic. The neonatal calf has very high 
nutritional needs due to the selective transfer of molecules through the placenta. The 
neonatal calf needs immunity, energy, protein, vitamins and minerals for it to survive. At 
birth, the calf has only 3 % body fat, which is critical for development, and therefore, not 
available as an energy source (Akers, 2002). It is estimated that the total fat and 
glycogen available to the calf at birth would be used up in about 18 h without 
supplemental feeding (Davis and Drackley, 1998). The limited amount of glycogen 
stored in the liver or other tissues is rapidly used, and gluconeogenesis is limited in the 
liver at this time. Mother Nature has compensated for the lack o f Ig and nutrients passed 
through the placenta by having the first secretion from the mammary gland, known as 
colostrum, being an excellent source of both immunological protection and nutrients 
needed for survival.
Characteristics of the gastrointestinal tract. Another important aspect concerning 
the neonatal calf is that the rumen is nonfunctional. At birth, the abomasum accounts for
3
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about 70% of the volume of the entire stomach. The rumen, reticulum, and omasum 
account for the other 30%. This is dramatically different from the mature animal where 
the forestomach (rumen, reticulum, and omasum) accounts for more than 90% and the 
abomasum less then 10% of the stomach (Church, 1988). This makes a neonatal ca lf s 
digestive system similar to simple stomach animals such as the pig and human.
Milk bypasses the rumen and flows directly into the abomasum through the 
formation of the esophageal groove. The esophageal groove is formed through the 
muscular folds of the reticulum (Church, 1988). Neural stimulation from suckling and 
milk proteins results in the formation of the groove, extending the esophagus to the 
abomasum. Due to the specific proteins found in milk, colostrum, and milk replacer the 
esophageal groove will form whether calves drink from a bottle or bucket. However, 
water alone will not cause the groove to form resulting in water entering the rumen 
(Church, 1988).
Immunity Overview
The immune system is composed of two defense mechanisms, cell-mediated 
immunity and humoral immunity. Cell-mediated immunity involves T lymphocytes (T 
cells) which protect the body against cells that have been infected by viruses, parasites, or 
even cancer cells (Akers, 2002). Humoral immunity is comprised of B lymphocytes (B- 
cells) that can differentiate into plasma cells, which secrete antibodies. Antibodies also 
known as immunoglobulins are antigen-binding glycoproteins present on the B-cell 
membrane and secreted by plasma cells (Goldsby, 2003). The roles of antibodies are to 
bind to bacteria and their toxins or to bind to free viruses, making them inactive (Akers, 
2002). The antibody-antigen complex results in the antigen being susceptible to
4
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destruction by phagocytes or complement activation (Akers, 2002). There are five major 
classes of Ig: IgA, IgG, IgM, IgD, and IgE, all of which have a specific function within 
the immune system. The prevalence of a certain class o f Ig depends on the species of 
animal. Ruminants have nearly all their Ig as IgG, while humans have more than 80% of 
their Ig as IgA (Akers, 2002).
The humoral immune system is comprised of memory B cells, which are 
responsible for the increase in antibody concentration when an animal is exposed to the 
same pathogen a second time. The memory B cells have the ability to recognize a 
pathogen in which the body has already been exposed, thus allowing for a faster immune 
response that will destroy the pathogen, preventing the animal from becoming ill.
At birth the ca lf s immune system is immature, resulting in its inability to make Ig 
and fight the pathogens it becomes exposed to at birth. The calf receives the Ig required 
to fight disease through the cow’s colostrum it ingests. The cow has already been 
exposed to pathogens on the farm resulting in her immune system having specific Ig that 
can recognize and destroy this harmful pathogen. When the calf consumes the colostrum 
it is also ingesting these pre-made Ig, resulting in the calf having the Ig required to fight 
the pathogens it is exposed to and increasing its chances of survival.
Immunoglobulin Structure and Function
Each antibody molecule is comprised of two identical heavy chains and two 
identical light chains, which are linked together by disulfide bonds (Akers, 2002). The 
shape o f the antibody molecule resembles the letter Y with the two heavy chains making 
up both the arms and stem. The light chains overlap portions of the heavy chains in the 
arms, and are joined to the heavy chains by a disulfide bond and by noncovalent
5
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interactions such as salt linkages, hydrogen bonds, and hydrophobic bonds to form a 
heterodimer (Goldsby, 2003). The two identical heavy chains forming the stem of the Y 
are also linked together by noncovalent interactions and disulfide bonds (Goldsby, 2003). 
The two arms are classified as the Fab portion and the stem is considered the Fc domain 
(Rojas and Apodaca, 2002). The sites for binding of the antibody to the antigen are found 
at the two top ends of the Fab portion. These sites are known as the V regions (variable 
region) due to their highly variable sequence of 110 or so amino acids. The sequence of 
these amino acids determines the Ig specificity to an antigen (Goldsby, 2003). One Ig 
molecule is capable o f binding at least two antigen molecules making the Ig divalent 
(Akers, 2002). The Fc domain interacts with molecules such as complement or Fc 
receptors, marking the antibody-antigen complex for destruction by, either neutralization, 
precipitation, agglutination, or opsonization (Akers, 2002).
Structure of an IgG Molecule
Ch’
P apain
 SS— s s H inge
CHO
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Immunoglobulin G. IgG has a molecular weight o f 180,000 (Anderson et al., 
1985) and is the most abundant class of antibodies found in blood serum and lymph. In 
all animals, IgG works to fight against bacteria, fungi, viruses, and foreign particles. It is 
the smallest Ig, which allows it to leave the blood stream and enter body pools were it can 
fight antigens. Immunoglobulin G is divided into subclasses IgGl and IgG2, with IgGl 
being the most prevalent in the bovine serum. The structural characteristics that 
distinguish these subclasses from one another are the size of the hinge region and the 
number and position of the interchain disulfide bonds between the heavy chains 
(Goldsby, 2003).
Immunoglobulin M. IgM is the class of antibodies found in circulating body 
fluids. It has a molecular weight of 900,000 and is expressed as a membrane bound 
antibody on B cells (Anderson, 1985; Goldsby 2003). It is comprised o f five monomer 
units held together by disulfide bonds, resulting in its pentamer shape. This 
distinguishing characteristic allows IgM to be much more efficient then IgG when 
neutralizing a viral infection or activating the complement system. Immunoglobulin M 
can bind 10 small molecules or 5 larger molecules where IgG can only bind two at the 
most (Goldsby, 2003). Immunoglobulin M is the first antibody to appear in response to 
an initial exposure to an antigen (Goldsby, 2003). Due to the large size o f IgM, it does 
not diffuse well and therefore found in very low concentrations in the intracellular tissue 
fluids; however, it does play an important accessory role to IgA as a secretory molecule 
(Goldsby 2003).
Structure of IgM molecule 
7
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Immunoglobulin A. Immunoglobulin A has a molecular weight of 380,000 
(Anderson et al, 1985) and is an antibody whose main function is to fight ingested 
antigens. It is found in mucosal and exocrine gland secretions (Rojas and Apodaca,
2002). The highest level o f IgA secreted is by the intestine due to the constant interaction 
with endogenous flora and external microbes (Didierlaurent et al, 2002). To compensate 
for the lack o f a fully functional immune system in the neonatal calf colostrum contains 
IgA, which coats the intestinal lining, preventing pathogens from attaching and causing 
disease. Immunoglobulin A binds antigens such as bacteria, viruses, parasites, and 
toxins. This Ig works by preventing the attachment and invasion of external pathogens 
into the mucosal surface by hindering their motility. For example, IgA can inhibit 
flagella function, induce microbial aggregation, compete with pathogens for adhesion 
sites, and to neutralize viruses (Williams and Gibbons, 1972). Immunoglobulin A and 
antigen complexes are entrapped in mucus and then eliminated by the ciliated epithelial 
cell of the respiratory tract or by peristalsis of the gut (Goldsby, 2003).
Colostrum
Colostrum is the first secretion from the mammary gland after calving and is 
designed to meet the nutritional needs of the neonatal calf. Bovine colostrum is 
composed o f 14% protein, 6.7% fat, and 2.7% lactose, while milk, which is classified as 
about the sixth milking or the third day after calving, has 3.1% protein, 3.5% fat, and 5%
Structure of IgA molecule
8
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lactose (Akers, 2003). As for Ig, bovine colostrum is composed of 75% IgG, 12% IgM, 
and 12% IgA while bovine milk contains only about 0.6% IgG and even lower levels of 
IgM and IgA (Foley and Otterby, 1978). Colostrum supplies the newborn with its first 
line of defense, nutrients, and growth factors.
Colostrogenesis. Colostrum is formed through the process known as 
colostrogenesis. Colostrogenesis is a process during late gestation, which results in the 
transfer o f serum IgG into the mammary gland (Holland, 1990). Blood IgG enters lacteal 
secretions by a specific intracellular transport mechanism (Anderson et al., 1985). 
Immunoglobulin G is divided into two subclasses, IgGl and IgG2. Immunoglobulin G1 
is the most prevalent immunoglobulin found in bovine colostrum. It occurs in 
concentrations 5-20 times that of IgG2 due to the high prevalence of IgGl specific 
receptors on the secretory cells (Anderson et al., 1985). IgGl is transported from the 
serum to the colostrum, by first diffusing across the vascular epithelium and then 
selectively transported by mammary epithelial cells (Butler, 1983). Immunoglobulin G 
then specifically binds via Fc-specific receptors located on the basal membrane of the 
secretory epithelium (Butler, 1983). The basal membrane then engulfs the IgG molecule, 
which will then be released into the colostrum (Holland, 1990). The onset of lactogenesis 
rapidly decreases IgG transport, suggesting that the hormones responsible for alveolar 
cell differentiation may also suppress colostrogenesis (Akers, 2003). During the transfer 
of IgG from the serum to the colostrum, there is a significant decrease in maternal serum 
IgG and constant increase in colostrum IgG (Butler, 1983).
Immunoglobulin M and IgA are less prevalent in bovine colostrum and rather 
then coming directly from the maternal blood serum they are synthesized in the
9
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mammary gland. They are synthesized in plasma cells lying adjacent to the secretory 
epithelium (Anderson et al., 1985). Following synthesis IgA binds to a protein receptor 
known as the secretory component, forming a complex called secretory IgA (slgA), 
which consist o f two IgA molecules, the J chain, and the secretory component (Anderson 
et al., 1985). Secretory IgA then moves through the secretory cell to the apical surface 
and is discharged into the colostrum (Anderson et al., 1985). The pathway of IgM is 
believed to be similar to IgA.
Colostrum Quality. The quality of colostrum is classified according to its IgG 
concentration; low quality < 22 mg of IgG/mL, medium quality 22 to 50 mg of IgG/mL, 
and high quality > 50 mg of IgG/mL. The IgG concentration is often measured indirectly 
using a colostrometer. The colostrometer measures the specific gravity of the colostrum, 
which equates to the Ig level. The higher the specific gravity the higher the colostrum 
quality.
The quality varies between breeds and the parity o f the cow. Jerseys have higher 
quality colostrum because they produce colostrum that has a higher percentage of solids 
then a Holstein cow (Akers, 2003). In addition, cows that produce less milk normally 
have higher IgG concentrations due to the milk being more concentrated. A multiparous 
cow has higher quality colostrum, because it has been exposed to more pathogens and 
thus has built up a stronger immune system then a primiparous cow. If the calf is fed 
higher quality colostrum, they will have the amount of IgG required to fight disease... 
Colostral Nutrients
Protein. Colostrum is composed of 14% protein. Proteins are synthesized from 
amino acids derived either from the blood stream or from amino acids synthesized by the
10
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secretory cells (Akers, 2002). Consumption of large amounts of amino acids is critical 
for the stimulation of protein metabolism in the neonatal calf (Quigley and Drewry,
1998). The neonate begins protein synthesis in the visceral organs, brain, lungs, and 
skeletal muscle, within a few hours after birth (Quigley and Drewry, 1998).
The primary milk protein casein, coagulates in the abomasum forming a clot of 
milk. Casein is then slowly digested, providing a source of amino acids between meals 
(Quigley and Drewry, 1998). Other proteins such as P-lactoglobulin and a- lactalbumin 
are simply degraded in the abomasum and quickly hydrolyzed into amino acids (Quigley 
and Drewry, 1998). The large mass of Ig in colostrum provides an important source of 
amino acids even though they are more slowly digested (Quigley and Drewry, 1998).
The neonate will establish homeostasis once enough amino acids are available for protein 
synthesis and gluconeogenesis (Quigley and Drewry, 1998).
Other proteins such as lactoferrin (Lf) and transferrin have a bioactive role in the 
nonspecific defense to a bacterial infection. They have the ability to inhibit growth of 
Gram-positive and Gram-negative bacteria because of their ability to sequester iron and 
limit its use by the bacteria (Akers, 2002). Properties of Lf will be discussed further in 
part 2.
Energy. The high fat content of colostrum (6.7% ) is important to the neonate 
immediately after birth. The neonatal calf only has 3% body fat resulting in the neonate 
having poor insulation (Akers, 2002). The total fat and glycogen available to the calf at 
birth would be used up in about 18 h without supplemental feeding (Davis and Drackly, 
1998). The colostral energy content may affect the thermoregulation and fatty acid 
oxidation that are necessary to sustain gluconeogenesis (Quigley and Drewry, 1998). The
11
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faster the calf reaches homeostasis the higher its chances for survival (Santoro, 2001). 
Heat production was increased by 18 and 9% in the first and second hour after colostrum 
consumption in calves maintained in a 10°C environment (Vermorel et al., 1983)
Vitamins and Minerals. Fat soluble vitamins A, D, and E do not cross the 
placental barrier, resulting in colostrum being the primary source of these nutrients for 
the calf after birth (Quigley and Drewry, 1998). Supplementation of Vitamin A and E (a- 
tocopherol) to the dry cow diet is important to have adequate amounts of these nutrients 
in colostrum (Quigley and Drewry, 1998). Vitamins A and E are not present in the 
calves’ blood stream at birth, while Vitamin D may be synthesized by precursors in the 
calf s tissue (Santoro et al., 2004). Nemec et al. (1994) showed that Vitamin E improved 
the development o f cellular immunity in neonatal pigs. Vitamin A plays a role in 
maintaining a healthy epithelium, growth, bone formation, immune function, and protein 
synthesis (Rufibach et al., 2006; Franklin et al., 1998; De Luca et al., 1969).
Selenium crosses the placenta and may accumulate in fetal tissues, such as the 
liver. Dietary selenium (120mg of Se/kg) has been reported to increase colostral IgG and 
it absorption by the neonatal calf (Swecker et al., 1995). Colostrum is also more 
concentrated then milk in zinc, iron, folic acid, choline, and riboflavin (Akers, 2002). 
Passive Transfer
The transfer o f IgG from mother to neonatal calf through colostrum is known as 
passive transfer. This provides the neonate with a form of passive immunization, which 
is the acquisition o f immunity by a receipt of preformed Ig rather than by active 
production of Ig after exposure to antigens (Goldsby, 2003). The absorption of IgG 
across the small intestine appears to be species specific. In a number o f newborn animal
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species, selectivity has evolved to the exclusion of the transport o f nearly all proteins, 
such as man, guinea pig, and rabbit, whereas in others, such as the pig and the ruminant 
selectivity appears to be poorly developed. There is also an intermediate group of 
selectivity, which includes the rat, mouse, and perhaps carnivores (Staley and Bush, 
1985).
In the small intestine of neonatal mice and rats, the FcRn receptor is expressed at 
high levels by intestinal epithelial cells and mediates absorption of IgG by receptor- 
mediated transcytosis (Mayer et al., 2002). FcRn is a major histocompatibility complex 
class 1- related protein that mediates bidirectional IgG transcytosis in a variety of tissues 
(Rojas and Apodaca, 2002). Receptors are adapted to fit their attachment sites onto the 
Fc-portion of Ig (Staley and Bush, 1985). It appears the binding of IgG to the FcRn 
receptors is pFI-dependent (Jones and Waldman, 1972; Rodewald, 1976), occurring at a 
pH of 6.0 to 6.5, which is similar the pH of the luminal content of the small intestine 
(Staley and Bush, 1985). The FcRn expression is developmentally down-regulated, 
resulting in almost complete loss of intestinal FcRn at the time of weaning in mice 
(Mayer et al., 2002).
The mechanisim of IgG absorption across the small intestine of ruminants is less 
complex. Previous studies have shown the possibility of the absorptive epithelieal cells 
within the jejunum of the neonatal calf possessing receptors, such as mice and rats, which 
mediate the binding and cellular transport of Ig (Butler, 1983; Widdowson, 1985). Staley 
and Bush (1985) introduced IgG conjugated to ferritin, and ferritin suspended in boiled 
bovine colostral whey into the jejunum and observed the jejunal cells did not take up the 
ferritin, but ferritin conjugated to IgG was observed in the apical tubular complex. The
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conjugated ferritin was not transported into the vacuolar system of the cell and did not 
exit the cell. Cells in the ileum, however were the most active in the uptake of ferritin- 
IgG or ferritin. This study indicates the calves may have some selectivity in absorption, 
based on the particular protein rather then molecular weight in the jejunum. However, 
selectivity was not shown in the ileum in which both ferritin-IgG or ferritin were found 
(Staley and Bush, 1985).
It appears in more recent studies that absorption of IgG in ruminants occurs non- 
selectively during the first 24 h o f life by pinocytosis (Mayer et al., 2002). Pinocytosis is 
a type of endocytosis in which a cell ingests extracellular fluid and the material dissolved 
in it (Goldsby, 2003). Mayer et al. (2002) were not able to detect FcRn in enterocytes, 
which are the cells responsible for the initial absorption of intestinal IgG. This would 
support other studies that found Ig uptake to be a non-specific event. However, FcRn was 
expressed by the crypt cells of the newborn lamb, which may be responsible for IgGl 
being the major Ig in the secretions of the small intestine (Mayer et al., 2002). This 
indicates that FcRn is responsible for IgG being brought back into the mucosa from the 
neonate’s blood stream to fight infection along with IgA. No matter how IgG is absorbed 
across the small intestine, the passive humoral immunity supplied to the neonate at this 
time is essential for its survival.
Successful passive transfer is considered to be achieved when the serum IgG 
concentration is equal to or greater then lOg/L at 24 h after birth. The national dairy 
heifer evaluation project found that 40% of all calves sampled between 24 and 48 h had 
an IgG concentration o f < lOg/L and over 25% < 6.2g/L (Wells et al., 1996). The 
economic impact of failure o f passive transfer (< 1 Og/L of IgG) at 24 h after birth is
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substantial. Management procedures and products that improve passive immunity in 
calves are crucial to the dairy industry.
Gut Closure. Gut closure is the necessary phenomenon that allows for the 
maturation of the digestive system, resulting in the cessation of absorption of 
macromolecules from the small intestine by about 24 h after birth (Stott et al., 1979).
The maturation process o f the small intestine includes multiple events, such as intestinal 
cell turnover, increasing abomasum acidity, development of intestinal secretions, and 
appearance o f intra-epithelial digestive vacuoles.
Factors Effecting Passive Transfer
Time of First Feeding. Many factors affect whether or not the calf will receive 
successful passive transfer. Age of the calf at first colostrum feeding has a large impact 
on IgG absorption. An experiment by Haines et al. (1993) showed that serum IgG 
declined from over 14g/L when fed at birth to less then lOg/L when feed 6 h after birth. 
Only calves fed colostrum before 6 h had serum IgG levels greater then lOg/L. This is 
due to the maturation o f the intestinal tract, resulting in the loss o f absorptive sites in the 
small intestine. At birth there is also a limited amount of enzyme secretions, allowing 
IgG to pass to the small intestine where it can be absorbed as a whole molecule. By 12 h 
after birth enzyme secretions become more active, decreasing the chance of the IgG 
molecule to reach circulation. Quigley et al. (1995) showed that serum IgG and IgM 
concentration could be increased by adding lg  of soybean trypsin inhibitor to colostrum. 
The soybean trypsin inhibitor reduced the activity of trypsin in the small intestine 
allowing more o f the Ig molecules to be absorbed.
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Delaying the first colostrum feeding also enhances the risk of bacterial 
colonization o f the intestine. Bacteria can compete with IgG molecules for absorption 
sites, thus decreasing the amount of IgG absorbed. The ingestion o f bacteria also may 
accelerate the gut closure process. Logen et al. (1977) challenged calves with Escherichia 
coli either before or after the first colostrum feeding. Seventy-five percent of the calves 
receiving E.coli before colostrum feeding died while none of the calves that received 
colostrum first died.
Quantity and Apparent Efficiency of Absorption. In addition to the timing of 
colostrum ingestion, serum IgG concentration depends on the mass of IgG consumed 
(Kruse, 1970; Stott et al., 1979; Stott and Fellah, 1983). The mass o f IgG consumed 
depends on the volume o f colostrum fed, IgG concentration of the colostrum, and the 
efficiency of absorption of IgG by the calf (Morin et al., 1997).
The apparent efficiency of absorption (AEA) is equal to 
[Plasma IgG at 24 h (g/L) x BW(kg)x0.092]/IgG intake(g)], with 0.092 representing the 
average blood volume (9.2% of BW) (Quigley et al., 1998). Research data suggest that 
the average AEA of IgG from maternal colostrum is about 35% (Quigley and Drewry, 
1998). This data indicates that an average newborn weighing 40 kg must consume at 
least 103 g of IgG by 24 h to achieve a blood serum concentration o f lOg/L (Quigley et 
al., 2002). In order to consume at least 103 g of IgG, the calf must ingest a minimum of 
2.1 L of high quality colostrum (50g/L) within 2 hours after birth, for successful passive 
transfer to occur.
Levieux and Oilier (1999) estimated that 18% of dairy cows produce colostrum 
yielding less then the required amount of 100 g o f IgG, for successful passive transfer.
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Do to this variability in colostrum quality and variability in calf birth weight, it is 
recommended that the calf receive 4 L of high quality colostrum within the first 12 h of 
life. The main practice on dairy farms involves feeding 2 L at birth and another 2 L at 12 
h later. If a total of 4 L of high quality colostrum (>50mg/ml of IgG) is fed either in one 
feeding or split into two feedings then the calf should receive the desired amount of 103g 
of IgG within the first 12 hours of life (Kruse, 1970).
Method of Feeding. The method of feeding colostrum also has an effect the calf s 
ability to receive passive transfer. There are three management practices used on the 
dairy farm to administer the first colostrum feeding. The first method is to allow the calf 
to nurse from the dam. However, having the calf nurse from the dam increases its risk of 
failure of passive transfer. The calf may have difficulty finding the udder and ingest 
bedding and feces, which may contain harmful bacteria. In addition, when nursing from 
the dam one cannot determine the amount, o f colostrum consumed. Without consuming 
sufficient quantities of colostrum, the calf will not be able to obtain the required amount 
of IgG to prevent failure of passive transfer. The last concern when allowing the calf to 
nurse from the dam is the delay of standing which results in a delay of consumption.
The other methods of feeding are through the use of a bottle or an esophageal 
feeder. They both allow the farmer to control of the time and quantity in which the calf 
consumes the colostrum. However, studies show a slight increase in IgG absorption in 
calves feed by a bottle rather then the esophageal feeder. This is due to the different path 
colostrum takes though the gastrointestinal tract when an esophageal feeder is used. 
When a calf nurses from either the dam or the bottle, the suckling reflex and milk 
proteins cause the formation o f the esophageal groove. The formation of the esophageal
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groove results in the milk by passing the rumen and flowing directly into the abomasum. 
In the method of using an esophageal feeder the esophageal groove does not form, 
resulting in the colostrum being deposited into the nonfunctional rumen. It then takes the 
milk two to four hours to leave the rumen, which may result in lower AEA due to the 
decrease in absorption sites over time.
Disease risk associated with colostrum feeding
Johne’s Disease. Johne’s Disease is a contagious disease of the intestinal tract 
caused by the bacteria Mycobacterium Paratuberculosis. The ileum becomes thick due to 
an inflammatory response caused by the infection. This prevents the intestine from 
functioning normally. The animal will continue to eat normally but will be unable to 
absorb nutrients resulting in the animal becoming anorexic and eventually dying.
Johne’s has an incubation time of 2 to 5 years, in which time the animal may not 
be showing signs o f the disease but still shedding the bacteria. Johne’s is age dependent, 
meaning it takes a smaller dose to infect a calf then it would to infect an adult cow. This 
results in calves less than 6 months of age being the most susceptible. The bacterium is 
spread through manure, milk, and colostrum. The probability o f calves becoming 
infected by drinking milk from infected cows is a direct function of time spent with the 
cow. If the calf remains with the cow for an extended period of time, she will have 
nursed more often thus having more exposure to the bacteria, either through ingestion of 
the colostrum or o f manure on teats.
It is estimated that >22% of United States dairies are infected with Johne’s 
disease and that it costs the producers $245 per cow/yr and the United States’ dairy
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industry $200-250 million annually (NAHMS, 2002). The high costs are due to a 2-19% 
reduction in milk yield, increased cull rate, and greater mortality.
Bovine Leukosis Virus. Bovine Leukosis Virus (BLV) is a virus that survives in 
the lymphocytes and once the animal is infected, it is infected for life. NAHMS (2002) 
reported that 89% of United States dairy operations have cattle infected seropositive for 
BLV. The virus survives in the lymphocytes, which are found in blood, milk, and 
colostrum along with other body fluids. If the calf ingests the BLV containing colostrum 
or milk, it will become infected. There is also a 4-8% chance of BLV crossing the 
placenta and infecting the fetus. However, only 5% of the cows infected with the virus 
ever develop the clinical diseases because it does not show up until later in life. In 
addition, it may remain dormant until brought on by stress.
Bovine Leukosis Virus causes a reduction in milk production and reproductive 
performance. The reduced performance is caused by tumors, which may develop in the 
abomasum resulting in loss of appetite, and tumors developing on the uterus. The largest 
economic impact o f BLV is the number of carcasses condemned at slaughter plants. The 
number of condemned carcasses at slaughter has tripled since 1975. This is based on the 
number o f lymph node tumors, indicating that a stronger elimination program needs to be 
established. In addition, purebred breeders suffer the biggest economic losses, because 
buyers do not want to bring the virus into their herd. The vims can also be spread 
through the semen, so many major artificial insemination companies will only accept 
semen from bulls that test negative.
There are other diseases such as BVD and salmonella that can be transferred to 
the calf through the ingestion of colostrum. Both can be detrimental to the calf s health
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and increase their chances o f morbidity and mortality. Management procedures need to 
be implemented on dairies, which minimize the spread of disease through colostrum 
feeding. This will then result in an overall healthier and more productive herd. 
Colostrum replacer and supplements
The recognition o f high rates of failure of passive transfer (FPT) in calves and the 
risk of transferring disease to calves has lead to areas of research which would provide 
additional IgG or an alternative source of maternal colostrum. Dairy producers now have 
the option o f feeding a colostrum replacer or colostrum supplement when high quality 
maternal colostrum is not available. Colostrum replacements may also be used as a part 
o f biosecurity programs to prevent transmission of disease-causing organisms such as 
Salmonella spp, Mycobacterium paratuberculosis, bovine leukemia virus, and bovine 
viral diarrhea virus (Foster et al., 2006). Colostrum replacer is defined as having > 100 g 
IgG/dose and providing other nutrients required by the calf (Quigley et al., 2002b). A 
colostrum supplement has < lOOg IgG/dose and is not formulated to replace maternal 
colostrum but rather be fed with it (Quigley et al., 2002b). Supplements do not provide 
the necessary energy, amino acids, or vitamins and minerals necessary for the ca lf s 
development. Colostrum replacers and supplements were introduced into the market in 
the mid to late 1980’s and have become an important class of products for producers. 
Annually more then 500,000 calves in the U.S. are treated with colostrum products as a 
means of improving success of passive transfer and reducing cost associated with 
neonatal disease. Three sources of IgG that may be used in formulating colostrum 
supplements and replacers are lacteal secretions (colostrum and milk), blood, and eggs.
20
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Lacteal Secretions. Colostrum supplements or replacers from lacteal secretions 
are derived from dried colostrum or whey secretions. Though these products maybe 
convenient and have been shown to protect calves under some circumstances, the Ig 
content is highly variable. Colostrum supplements have been found to range from 0.3 
grams to 17.8 grams of IgG per dose, resulting in the calf being at a risk of FPT if only 
fed a colostrum supplement (Haines et al., 1990; Hunt and Hunt, 1991). The production 
of an effective replacer for bovine colostrum is dependent upon processing only 
colostrum containing high Ig concentrations and upon having an efficient method of 
dehydration, which preserves Ig function (Chelack et al. 1993). In a study conducted by 
Chelack et al. (1993), only colostrum collected from the first two postpartum milkings of 
multiparous cows contained sufficient immunoglobulin mass to be suitable for processing 
into a colostrum replacer. Chelack et al. (1993) also tested three dehydration methods of 
colostrum; freeze-dried, microwave vacuum evaporation, and spray-dried colostrum. 
Freeze-drying was found to be the most effective method for maintenance of Ig function 
and recovery of total solids. However, the lengthy processing time, high energy 
consumption, severely limited processing capacity, and high maintenance costs resulted 
in freeze-drying of large volumes of colostrum not being economical. The spray-drying 
method was the fastest and most energy efficient, costing 2.5 times less than either 
freeze-drying or microwave vacuum evaporation (Chelack et al, 1993). Spay-drying 
involves having atomized droplets of colostrum contact a countercurrent o f hot air, 
resulting in heat transfer which promotes dehydration (Chelack et al. 1993). The spray- 
dried colostrum retained 94% of the Ig mass with minimal loss of Ig function; however, 
there was a 25% loss in total solids (Chelack et al, 1993). The end result was a product
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that provided 126 g o f IgG when fed to calves. The serum IgG at 48 h of age was 11.6 
and 10.6 g/L for calves fed the colostrum and spay-dried colostrum, respectively. 
However, even with these developments of processing colostrum products that contain 
the required amount o f lOOg of IgG/ dose, no milk- or colostrum-based replacer products 
have been shown to routinely result in serum IgG concentrations > lOg/L (Foster et al., 
2006).
Mee et al. (1996) conducted a study in which a whey protein concentrate (WPC) 
was fed as a colostrum substitute and compared to maternal colostrum. Calves fed the 
WPC alone had a 24 hour serum IgG concentration of only 3.0 mg/mL compared to 
calves fed maternal colostrum which had a serum IgG concentration of 17.8mg/mL. This 
resulted in calves fed the WPC having a higher mortality rate (P < 0.05). The WPC was 
derived from ultrafiltrated and freeze-dried cheese whey collected from thousands of cow 
in North America. This processing method alone would result in high variability in IgG 
and nutrients within the product itself. Other studies have compared commercially 
available colostrum-based replacement products and evaluated their effect on serum IgG. 
These studies (Foster et al., 2006; Garry et al., 1996) found a high variability in 
colostrum replacement products alone, with some colostrum based products providing 
sufficient IgG for passive transfer while other products did not, even if all products 
provided the required amount of >100g of IgG/dose. It is estimated that the AEA of 
colostrum replacer based on lacteal secretions ranges form 5 to 30% (Mee et al., 1996; 
Arthington et al., 2000). The variability of AEA among products and within the product 
itself results in the high variability of whether a calf will receive passive transfer when 
fed a lacteal secretion based colostrum replacer. In addition, with maternal colostrum
22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
having an AEA of 35% would also explain why calves fed maternal colostrum have a 
higher percentage rate o f successful passive transfer. The reason for the lower AEA in 
colostrum products is yet to be fully understood.
Bovine Serum Extracts. Colostrum replacer/supplements derived from serum 
protein generally have an AEA of 25-30%, which is higher then lacteal secretion based 
products and similar to maternal colostrum (Arthington et al., 2000; Quigley et al., 1998). 
It is also the least expensive source since bovine blood is plentiful and considered a waste 
product from slaughter houses. It has high levels of IgG with little IgM and IgA.
Bovine blood is collected from sources that are under USD A inspection and 
approved for human consumption. Bovine serum powder can be prepared by removing 
fibrin by addition of excess Ca, and the resulting serum is concentrated by filtration and 
spray-dried to produce a light tan powder (Quigley et al., 2001). The bovine serum 
powder is then mixed with other ingredients so it will provide the calf with both its 
immunological and nutritional needs.
Quigley at al. (2001) demonstrated that the method used for fractionation of 
bovine plasma to manufacture CR influenced absorption of IgG. The results of this study 
showed that when polyethylene glycol was used in the fractionation process, plasma IgG 
concentrations in the calf were reduced. This may have been caused by altered 
absorption kinetics, equilibration of IgG with nonvascular IgG pools or metabolism of 
IgG by the body within the first 24 h Quigley at al. (2001). Polyethylene glycol is used 
widely as a method for purifying IgG from plasma, lacteal secretions, and eggs (Akita 
and Nakai, 1993; Svendsen et al., 1995; Uemura et al., 1989) and may be the result of 
lower AEA in colostrum products compared to maternal colostrum.
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Although, bovine serum based colostrum products are the most effective in 
assuring successful passive transfer when compared to other products, it is no longer 
allowed in countries where the use of animal proteins has been banned. This is due to the 
concern of diseases such as BSE being transferred from animals to humans during 
consumption.
Chicken Egg. Hens are hyperimmunized to produce IgY, which is the chicken 
form of IgG. The resulting eggs have high titers against the target antigen (Ikemori et al., 
1997). The eggs are concentrated and sprayed-dried. Egg IgY is used as a source of oral 
Ig, which only provides local protection in the small intestine. The IgY is not well 
absorbed across the small intestines (Kuroki et a.., 1993; Ikemori et al., 1997; Hennig- 
Pauka et al., 2003).
Limitations to colostrum products: There are many limitations to the use of 
colostrum supplements and replacers. For example, the profile of antibody specificity in 
a colostrum product may vary markedly from the antigenic reservoir on a dairy farm. 
Although the calf may absorb significant IgG, they may provide little protection if they 
are specific for the wrong pathogens. Biosecurity is also another potential risk when 
feeding an animal protein from an unknown source. Colostrum products may be exposed 
to such things as pasteurization and irradiation for the purpose of eliminating pathogens, 
however the risk o f transmission of disease is not completely ameliorated. Another 
negative aspect of colostrum products is that the processing steps such as pasteurization 
and spray-drying will reduce the activity o f important colostral components such as 
colostral lymphocytes and heat labile proteins. Lastly, the cost of feeding a colostrum 
supplement or replacer is expensive.
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Part 2; Lactoferrin
Introduction
Lactoferrin is an iron binding glycoprotein of the transferrin family. It is widely 
distributed in the physiological fluids of mammals (Saito et al., 1991). Unlike transferrin, 
which can be found in species as distant as insects, Lf can only be found in mammals, 
suggesting that its emergence had to do with infant nutrition and protection (Baker and 
Baker, 2005). Lactoferrin is believed to have evolved through the duplication of the 
transferrin gene at the time of emergence of mammals, with subsequent divergence in its 
amino acid sequence and functional properties (Baker and Baker, 2005). It can be found 
in fluids such as tears (Kiljistra et al., 1983), bronchial mucus (Fahy, 1993), secondary 
granules (PMN’s), (Bennett and Kokocinski, 1978), cerebrospinal fluid (Talukder, 2003), 
and milk (Molenaar et al.,1996).
Lactoferrin was first discovered in the whey fraction of cow’s milk (Sorensen and 
Sorensen, 1939). Its most striking characteristic was its intense red color when incubated 
in the presence of Fe3+ ions (Baker and Baker, 2005). The site of Lf synthesis is assumed 
to be the epithelia from which it is secreted (Sanchez et al., 1992).
The concentration of L f in milk varies between species and the stage of lactation. 
Humans have the highest concentration at 4 mg of Lf/ mL of milk, while rats and rabbits 
have no Lf (Sanchez, 1992), and in the cow, goat, and sow milk, the Lf concentration is 
between (20-200ug/mL) (Cowles et al, 2005). The concentrations of this protein have 
also been well documented for cows during colostrogenesis, lactation, and involution 
(Smith and Schanbacher, 1977). Lactoferrin is elevated in colostrum (1 to 2 mg/mL) but 
is low during lactation (0.01 to lmg/mL); Lf increases to between 20 and lOOmg/mL in
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the secretion that is produced during involution (Molenaar et al., 1996). There are also 
breed and parity effects, with dairy breeds having higher concentrations of Lf than beef 
breeds and multiparous cows having higher amounts than primiparous cows (Tsuji et al., 
1990). The health of the mammary gland also plays a role in the amount of Lf found in 
the milk. As the somatic cell count increases, so does the level of Lf (Harmon et al.,
1977). It is believed that the L f produced in the mammary gland may play a role in both 
protecting the mammary gland of the cow and the intestinal tract of the newborn from 
infection.
Lactoferrin plays a role in the innate immune system, which works as the first 
line of defense against infection. It has many biological functions such as antibacterial 
activity (Law and Reiter, 1977; Nonnecke and Smith, 1984; Reiter, 1983; Spik et al.,
1978), regulation o f Fe absorption (Fransson et al., 1983 and Kawakami et al., 1988), 
growth promotion of lymphocytes (Hashizume et al., 1983), product regulation of 
macrophage, and granulocyte and neutrophil leukocytes (Ambruso et al., 1981; 
Broxmeyer et al., 1980 and Hurlen et al., 1984), It could also control the development of 
intestine by promoting cellular growth (Sanchez et al., 1992).
Structure of Lactoferrin
Lactoferrin is a monomeric, 80-kDa glycoprotein with a single polypeptide chain 
of about 690 amino acid residues. It has a three dimensional structure comprised of two 
folded globular lobes, known as the N-lobe and the C-lobe. The N-lobe and the C-lobe 
share an internal amino acid homology of about 40% (Nuijens et al., 1996). A short a- 
helix peptide connects the lobes, and is the feature which readily distinguishes Lf from
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transferrin. It is helical in Lf, but irregular and flexible in transferrin, containing several 
proline residues (Baker and Baker, 2005).
Both the N-lobe and the C-lobe are divided into two regions. In each lobe, two 
a/p domains referred to as N1 and N2, or C l and C2, enclose a deep cleft where the iron 
binding site is located (Baker and Baker, 2005). The binding sites are comprised of four 
protein ligands (2 Tyr, 1 Asp, 1 His) that provide three negative charges, resulting in the 
binding site being highly anionic (Baker and Baker, 2005). This results in their strong 
affinity for cations such as Fe3+, with the three negative charges in the binding site 
balancing for the three positive charges of Fe . The two binding sites found on the Lf 
molecule allow for one L f molecule to bind to two Fe3+ molecules.
It is suggested that the binding of a carbonate anion occurs first, which allows for 
the neutralization of some positive charge near the iron binding site (Cowles et al., 2006; 
Robblee et al, 2002). The helix N-termini face the interdomain cleft, making it somewhat 
positively charged; H5 from N2 or C2 domain, serves as the binding site for essential 
carbonate anion at the metal binding site (Baker and Baker, 2005). This non-protein 
ligand (CO32' ion), is responsible for determining the pH in which iron is released (Baker 
and Baker, 2005). At a pH of 3-4 protonation of the carbonate ion occurs, causing a 
weakening of the Lf- Fe3+ bond, resulting in the iron release (Baker and Baker, 2005).
Lactoferrin can be found in two forms, holo-Lf (iron bond) or apo-Lf (iron free). 
The Lf found in secretions is almost entirely found in the apo-Lf state, with the capability 
of binding iron. The binding of iron results in the conformational change of the molecule 
becoming more compact. There is a 55° rotation of the N-lobe, and a 2 0 0 rotation of the 
C-lobe (Baker et al., 1998). The two domains of each lobe close over the bound metal
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and open to release it, resulting in the Lf-Fe3+ bond being reversible (Baker and Baker, 
2005). The apo form is more flexible because it does not have two metal ions to lock the 
lobes in place. The conformational changes associated with Fe3+ binding reduces the 
interaction between the bactericidal domain of Lf and the bacterial surface, thereby 
abolishing its antibacterial activity (Dionysius et al., 1993). The bactericidal domain, 
concentrated into a cluster of positively charged residues near the N-terminus of the Lf 
molecule (Vorland et al., 1998; Elass-Rochard et al., 1998; Nibbering et al., 2001), 
becomes less exposed in the holo-Lf configuration as opposed to the apo-Lf 
configuration.
There are also structural differences between species, with bovine lactoferrin 
sharing only 68% and 64% of amino acid residues with the human and murine 
lactoferrin, respectively (Nuijens et al., 1996). Depending on species the N- and C- lobes 
differ significantly in their relative orientations (Moore et al., 1997). In addition, all Lf 
appears to glycosylated, though with varying degrees from protein to protein, with human 
Lf having two glycosylation sites and bovine having four glycosylation sites (Baker and 
Baker, 2005). The structural differences of Lf between species could result in some 
activities of L f being species specific.
Lactoferrin Receptors
The multiple biological functions of Lf depend on its target cells and on the 
presence of specific receptors (LfRs) at their surface (Suzuki et al., 2005). The 
differences between tissues and cell types results in deferences in LfRs. Lactoferrin 
receptors of the small intestine in several neonatal species have been observed. However, 
in order for LfRs to function in the small intestine, Lf must pass through the
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gastrointestinal tract without proteolytic degradation (Suzuki et al., 2005). The relatively 
high pH and low enzyme secretion found in the neonate’s small intestine provide the 
environment for L f to pass through (Suzuki et al., 2005). The elevated Lf concentrations 
found in colostrum and the environment of the neonates’ gastrointestinal system, indicate 
L f may have a role in intestinal development. There is a variety o f suggested functions of 
the small intestine LfR such as facilitating iron absorption, enhancement of the immune 
system, and stimulating mucosal differentiation. However, results from studies are 
controversial and the mechanism is yet to be determined.
The binding of Lf to the LfRs on the brush border membrane vesicles (BBMV) 
appears to be time dependent, saturable, and specific (Davidson et al., 1988; Hue et al., 
1988). However, it appears in some species such as the adult bovine that transferrin can 
compete with L f to bind to the LfRs, thus reducing the percentage o f the Lf that becomes 
bound. (Talukder et al., 2003). Competitive binding experiments showed that holo- 
lactoferrin was more effective than less Fe-saturated forms of lactoferrin with regard to 
receptor binding (Lonnderdal, 1995).
Antibacterial Properties of Lactoferrin
Lactoferrin has been shown to inhibit the growth of many bacterial species, due to 
both its bacteriostatic and bactericidal properties. Its bacteriostatic activity is related to its 
ability to withhold iron while the bactericidal activity is not due to iron withholding. Iron 
is essential for bacterial growth; when Lf is present it binds the iron making it unavailable 
for the bacteria, resulting in the inhibition of bacterial growth (Dionysius et al., 1993).
The apo-Lf found in the extracellular compartments within the host body or host mucosal 
surfaces binds iron, resulting in the level of iron being below the required amount to
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support microbial growth (Finkelstien et al:, 1983). However, most pathogenic bacteria 
have developed ways in which they can overcome Lf- generated iron deprivation by 
acquiring iron by means o f two principal systems: either secreting small iron chelators 
(siderophores) or acquiring iron directly from host transferrin and L f (Valenti and 
Antonini, 2005). The siderophores compete with L f for iron, which then reduces the 
growth-inhibiting effect o f the protein. In the case o f acquiring iron directly from Lf, this 
involves binding Lf to bacterial receptors found on the bacteria (Gray-Owen et al., 1996). 
The Lf-bacteria binding causes a confirmation change in Lf, which lowers the affinity of 
Lf the C-lobe for iron (Ekins et al., 2004).
Bactericidal properties have also been shown in which there is a direct interaction 
between Lf and bacterial surfaces (Arnold et al., 1977). A non-specific binding between 
Lf and bacterial surfaces, of both Gram-negative and Gram-positive species, are caused 
by the high density of charges found on the surface of the Lf molecule (Baker et al., 
2002). Lactoferrin binds to the porins present on the outer membrane of Gram-negative 
bacteria (Gado et al., 1991), resulting in the release of lipopolysaccharides. This will 
enhance the susceptibility of the bacteria to osmotic shock, lysozymes, and other 
antibacterial molecules (Leitch and Willcox, 1998). In the case of Gram-positive bacteria 
its effect is likely to be similar to that of cationic and amphipathic antibacterial peptides 
(Valenti and Antonini, 2005). The positively charge Lf molecule binds to the negatively 
charge lipid matrix found in the membrane of Gram-positive bacteria through 
electrostatic interactions while the amphipathic residues disturb the non-polar membrane 
interior due to hydrophobic interactions (Giangaspero et al., 2001; Wessolowski et al.,
2004).
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Lactoferrin from several mammalian species have been shown to inhibit the 
growth of a number of bacteria, including human and/or animal pathogenic strains of E. 
coli, Salmonella typhimurium, Shigella dysenteriae, Listeria monocytogenes, 
Streptococcus spp., Vibrio cholerae, Legionella pneumophila, Klebsiella pneumonia, 
Enterococcus spp., Staphylococcus spp., Bacillus stearothermophilus and Bacillus 
subtilis (Valenti and Antonini, 2005). Lactoferrin reduces the growth of harmful bacteria 
in the gastrointestinal tract, while promoting growth of bacteria such as Lactobacillus and 
Bifidobacteria which are believed to be beneficial to the animal (Valenti and Antonini,
2005).
Antiviral Activity of Lactoferrin
Since 1994, potent antiviral activity of human Lf and bovine Lf has been 
demonstrated against both enveloped and naked viruses (Valenti and Antonini, 2005). 
Lactoferrin has been shown to have an effect on a variety of viruses in vitro such as 
cytomegalovirus, herpes simplex virus, human immunodeficiency virus, human hepatitis 
C and B viruses, rotavirus, and adenovirus (Valenti and Antonini, 2005). Lactoferrin 
may exert its effects by inhibition of viral fusion and entry into the cell, rather than 
stimulation of the immune system. Lactoferrin has been shown to inhibit antigen 
synthesis by the virus, it can interfer with the earlier stage of the virus (Superti F et al.,
1997). The antiviral activity of L f is the result of its strong affinity for heparin sulfate 
and glycosaminoglycan, carbohydrates that are the typical viral binding sites on the cell 
membrane (Andersen et al., 2001).
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Antifungal and Anti-parasitic Activity of Lactoferrin
The effect o f Lf on fungus is believed to be caused from adsorption to the cell 
surface rather than iron deprivation (Valenti et al., 1986). In vitro studies have shown 
that human Lf, bovine Lf, and lactoferricin are able to fight pathogenic fungi (Valenti and 
Antonini, 2005). The Candida species of fungi has been the most exclusively studied in 
Lf studies. The Lf growth-inhibitory effect appears to be much higher then those of most 
antifungal drugs currently available (Valanti and Antonni, 2005). The peptide 
lactoferricin either has two antifungal mechanisms, direct fungicidal activity or up 
regulation of the host defense (Gifford et al., 2005).
Anti-parasitic activities are complex and at this date unclear. In some species 
such as Pneumocytis carini L f appears to interfere with iron acquisition, while in other 
species such as Tritrichomonas foetus it appears to act as an iron donor, thus enhancing 
infection (Tachezy et al., 1996). In the case of lactoferricin, evidence indicates it may be 
attracted to the surface, resulting in the disruption of the membrane or the release of 
parasitic structural components that subsequently activate host defense systems (Gifford 
et al., 2005).
Antitumor Activity of Lactoferrin
Lactoferrin and lactoferricin have both been shown to have anti-tumor effects 
against leukemia (Yoo et al., 1997; Yoo et al., 1997), fibrosarcomas, melanomas and 
coloncarcinomas (Eliassen et al., 2002), without affecting normal fibroblasts and 
erythrocytes (Gifford et al., 2005). The changes, which occur in the membrane, such as 
exposure of phosphatidylserine, o f a tumor, cell results in Lfcin targeting the cell (Fadok 
et al., 2001). The bond o f Lfcin to the cancer cell disrupts the membrane marking,
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resulting in apoptosis (Aramaki et al., 2000). Lactoferrin itself has been shown regulate 
natural killer cells (Damiens et al., 1998; Shau et ah, 1992; Bezault et ah, 1994), G1 
protein modulation (Damiens et al., 1999), and inhibition o f vascular endothelial growth 
factor (VEGF)-mediated angiogenesis (Norrby et ah, 2001).
Anti- Inflammatory Activity of Lactoferrin
Lactoferrin has the ability to inhibit an inflammatory response through a variety 
of ways. First, L f can bind free iron that has accumulated in inflamed tissues and 
catalyzes the production o f tissue-toxic hydroxyl radicals (Legrand et ah, 2005). The 
PMN’s release o f the apo-Lf at the inflamed site, because of its iron-binding stability at 
low pH, it can precipitate in iron homeostasis and detoxification (Legrand et ah, 2005). 
Other anti-inflammatory properties involve its ability to inhibit the release of cytokines, 
which induce recruitment and activation of immune cells at inflammatory sites. It is able 
to reduce the release o f inflammatory cytokines by binding to the lipopolyscharide 
membrane of bacteria, through its lactoferricim domain (Appelmelk et ah, 1994; 
Brandenburg, 2001; Elass-Rochard et ah, 1995), resulting in the neutralization of LPS 
activity (Mattsby-Baltzer et ah, 1996; Zhang et ah, 1999). Lactoferrin is also considered 
a marker of inflammatory disease because its concentration increases during 
inflammatory diseases such as septicemia (Bennet et ah, 1978), rheumatoid synovitis 
(Caccavo et ah, 1999), bowel disease (Kane et ah, 2003), and neurodegenerative disease 
(Fillebeen et ah, 2001).
Lactoferrin Effect on Intestinal Development
Previous research with other species such as the human infant indicates that LF 
has a stimulatory effect on cell proliferation, increased cell size and growth of gut-
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associated lymphatic follicles (Artym and Zimecki, 2005). The weight of the small 
intestine o f neonatal mice has been shown to increase by about 27% when they consumed 
milk containing 12 mg/mL of human lactoferrin (Zhang et a l, 2001). In the same study 
by Zhang et al. (2001), the intestinal length increased only by about 6.5% indicating Lf 
enhances mucosal growth. In a study by Humphrey et al. (2002), greater villous height 
and fewer leukocytes were observed in the lamina propria in chicks when 5% Lf 
(0.125g/kg) and 10% lysozyme (0.3g/kg) were added to the diet. The increased villous 
height and surface area resulted in better nutrient digestion and absorption, thus 
improving feed efficiency. The fewer leukocytes were the result of a decrease of 
microbial challenges, thus improving intestinal health. The 5% Lf alone had no effect, 
while 10% lysozyme only had a slight increase on intestinal development. The 
combination o f L f and lysozymes resulted in a synergistic effect, by L f causing the 
release of LPS, which enhances the bacteria’s susceptibility to lysis by lysozymes 
(Humphrey et al., 2002). In calves, the data of Lf having a role on intestinal development 
is controversial. Joslin et al. (2001) and Robblee et al. (2002) found feed efficiency to 
increase when L f was supplemented to milk replacer, while Cowles et al. (2006) 
observed no effect o f L f on xylose and glucose absorption.
Lactoferrin in the Mammary Gland
The biological roles of Lf to modulate the control of macrophage, lymphocytes, 
and neutrophil function and its antibacterial properties aid in the immunity of the 
mammary gland (Sanchez and Watts, 1999). Lactoferrin concentrations increase in 
mammary secretions of dairy cattle during mastitis and mammary involution (Harmon et 
al., 1976;, Rejman et al., 1989; Welty et al., 1976). Mammary involution is a critical time
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for restoring mammary health. It is estimated that mastitis costs the dairy industry two 
billion dollars per year. Incidence of mastitis is particularly high in dairy cows during 
early involution, but the gland becomes more resistant to infection in the mid dry period 
(Oliver and Sordillo, 1989). The concentration of Lf increases from 0.4 mg/mL at drying 
off to 20 to 30 mg/mL by 30 d of involution (Smith and Oliver, 1981; Smith and 
Schanbacher, 1977), and by 30 fold during acute bovine mastitis (Schanbacher et al., 
1993,1997), indicating Lf may play a role in protecting against intramammary infection.
Cows are commonly treated at dry-off with a combination of penicillin and 
novobiocin to protect against intramammary infection (Sanchez and Watts, 1999). 
Novobiocin is able to inhibit the growth of Gram positive bacteria but not Gram negative 
bacteria due to its inability to penetrate the lipopolysaccharide membrane (Oram et al
1996). However, Lf has been shown to damage the outer membrane of Gram negative 
bacteria by causing the release of LPS molecules from the outer membrane. The increase 
o f Lf during involution may result in Lf disruption of the membrane of bacteria such as 
E. coli. This would result in novobiocin attacking Gram negative bacteria and destroying 
them. Although Sanchez and Watts (1999) showed that there was a synergistic effect 
between Lf and novobiocin in on E. coli bacteria in vitro, there was no reduction in 
bacterial counts in vivo.
Diarra et al. (2001) compared the effect of Lf in combination with penicillin on 
the morphology and the physiology of Staphylococcus aureus isolated from bovine 
mastitis. Staphlyococcus aureus is an important human and animal pathogen that is the 
most common cause of bovine mastitis, causing a loss of milk production (Forsmen et al.,
1997). Diarra et al., (2001) found that combining penicillin with relatively low
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concentrations of bovine lactoferrin lead to the synergistic increase of the antibacterial 
activity of this antibiotic to Staphlococci strains isolated from clinical bovine mastitis. 
There was no effect when penicillin was used as the only treatment due to the bacteria’s 
resistance to the antibiotic and Lf alone only had a small inhibitory effect. Although the 
two combined in vitro can induce destruction of the bacteria, the mechanism of action is 
not yet estabilished (Diarra et al., 2001).
The loss of the synergistic effect in vivo may be due to decreased activity of 
antibiotics, or the Lf present in bovine mammary secretions during involution exist as 
complexes with other macromolecules, which may alter Lf antibacterial activity (Wang 
and Hurley, 1998). Lactoferrin commonly binds to macromolecules, such as Ig, casein, 
secretory components, albumin, lysozyme, and (3-LG (Hurley, 1993; Lampreave et al., 
1990), as well as to DNA and heparin (Zou et al., 1992). The biochemical nature and 
functional significance of complexes between Lf and other macromolecules are 
unknown, but the may reduce Lf antimicrobial activity, or when bound to Ig, they may 
enhance antimicrobial activity (Wang and Hurley, 1998). However, human Lf and IgA 
act cooperatively with increased bacteriostatic activity (Stephens et al., 1980). 
Lactoferrin Fed to Dairy Calves
A dairy calf is exposed to a variety of pathogens that result in illnesses such as 
respiratory disease and scours. The biological functions of Lf as discussed could have 
multiple benefits in fighting these diseases However, the research involving feeding Lf 
to dairy calves has resulted in conflicting data.
The effect of supplemental Lf (0,1, lOg/d) in a conventional milk replacer on 
preweaning growth, blood, and health characteristics was studied by Joslin et al. (2002).
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Results indicate that calves receiving supplemental Lf had higher starter intakes, 
increased average daily gains, and increased heart girth measurements. It was also shown 
that calves fed 1 g/d o f L f had greater average daily gains then calves fed the 10 g/d 
treatment. The follow up study of Robblee et al. (2003) was designed to determine the 
optimum level of Lf to achieve the greatest response in health, growth and weaning of 
dairy calves. When supplementing non-medicated milk replacer with 0, 1, 2, or 3 g o f Lf 
per day, results indicated lg/d of Lf was the optimum level for good calf performance. 
Preweaning fecal scores and total days medicated showed a quadratic response w ithlg 
having the lowest score. There was also a linear effect in calves supplement with LF on 
the preweaning average daily gain and feed efficiency, however it did not maintain the 
same effect postweaning. These studies indicate that lg/d of supplemental Lf would be 
beneficial to the dairy calf, possibly by aiding in the immune system of calves by 
destroying pathogens, which may result in illness. However, in a study conducted by 
Cowles et al. (2006), in which they compared the effect of 0 or lg/d o f L f in both a 
conventional or intensified milk replacer, there was no increase in starter consumption, 
average daily gain, feed efficiency, or fecal scores between Lf treatments. The difference 
in results between studies could be caused by the difference in days medicated. In the 
study by Cowles et al. (2006), Calves had at least 50% lower fecal scores and day’s 
medicated then calves used by Joslin et al. (2002). These findings indicate that 
supplemental L f is only beneficial when calves are sick
Not only would the antibacterial properties of Lf be beneficial to the dairy calf, 
but its ability to influence the development of intestinal epithelia would also be 
considered beneficial (Nicholas et al., 1987; Van Leeuwen et al., 2000). The theory
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being if L f increases intestinal development, then nutrient absorption will increase. 
Schottstedt et al. (2005) investigated the effects o f dietary bovine L f and vitamin A alone 
or in combination on epithelia of the small intestine and colon and on the gut-associated 
lymphoid tissues, especially of Peyer’s patches (PP). In this study, they found a variety 
of positive and negative results depending on which location of the GIT was measured. 
First, plasma L f concentrations in all formula plus Lf fed calves remained low, indicating 
Lf was not absorbed. It was also found that crypt cell proliferation of the colon was 
negatively affected by Lf supplementation. However, the duodenum of calves fed the 
formula supplemented with Lf had a thicker tunica muscularis layer then calves fed 
colostrum, indicating that orally administered Lf might have an effect on both protein 
synthesis (Burrin et al., 1996) and on GIT muscle synthesis.
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CHAPTER II
Serum IgG Concentration of Neonatal Calves Fed Colostrum Replacer
Supplemented with Lactoferrin
Introduction
The neonatal calf is bom hypogammglobulinemic. Successful passive immunity is 
dependent upon adequate consumption and absorption of IgG soon after birth. Passive 
immunity is reliant on a variety o f factors such as quality and quantity o f colostrum fed 
(Morin et al., 1997), apparent efficiency of IgG absorption (AEA) (Morin et al., 1997), 
age of first feeding (Stott et al., 1979), stress (Hough et al., 1990; Johnston and Stewart, 
1986; Stott, 1980), and method of feeding (Lateur-Rowet and Breukink, 1983).
Successful passive transfer is defined as having a blood serum concentration of > 10 mg 
of IgG/mL at 24 h after birth. Blood serum concentrations < lOmg o f IgG/mL at this 
time are related to calf morbidity and mortality (Besser and Gay, 1994), as well as long 
term depressed calf performance (Wittum and Perino, 1995). The national dairy heifer 
evaluation project found that 40% of all calves sampled between 24 and 48 h had an IgG 
concentration of < lOmg/mL and over 25% < 6.2mg/mL (Wells et al., 1996). There is a 
need for improvement o f management procedures on the farm and development of 
products that will increase the number o f calves that acquire passive immunity 
(Arthington et al., 2000).
The recognition of high rates of failure of passive transfer and the risk of 
transferring disease to calves through maternal colostrum has led to areas of research,
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evaluating alternative sources of maternal colostrum. Maternal colostrum is the best 
source of Ig and nutrients for the calf. However, good quality colostrum is not always 
available. Alternative sources of providing Ig and nutrients to the calf have been 
developed such as colostrum replacer (CR) and colostrum supplements. These products 
are derived from a variety of sources such as lacteal secretions, blood serum, and eggs. 
Colostrum replacer is defined as containing > 100 g IgG/dose and providing other 
nutrients required by the calf (Quigley et al., 2002a). A colostrum supplement contains < 
100 g IgG/dose and is not formulated to replace maternal colostrum but rather be fed with 
it (Quigley et al., 2002a). Supplements do not provide the necessary energy, amino acids, 
or vitamins and minerals necessary for the ca lf  s development. Although CR contain the 
required amount of lOOg of IgG when fed at recommended levels, no milk or colostrum 
based replacer product has routinely shown results of serum IgG concentrations > 
lOmg/mL in dairy calves (Garry et al., 1996; Mee et al., 1996; Hopkins and Quigley, 
1997; Arthington et al., 2000). The reason for poor IgG absorption o f colostrum 
replacers and supplements has yet to be determined. Colostrum replacer not only needs 
to replicate maternal colostrum in its energy, protein, fat, mineral and vitamin content, 
but also other bioactive proteins such as lactoferrin (Lf). , Lactoferrin is an iron binding 
glycoprotein present in colostrum and milk. The concentration o f L f in bovine colostrum 
is 1 to 2 mg/mL, compared to bovine milk which only has a concentration of 0.01 to 1 
mg/mL (Molenaar et al., 1996). Lactoferrin has been shown to be important for intestinal 
development and development o f the immune system in species such as mice and humans 
(Shah, 2000). It has three functions, which may be beneficial to the development of a 
neonatal calf: inhibiting bacterial growth (Teraguchi et al., 1994), increasing intestinal
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cell growth (Zhang et al., 2001), and stimulating glucose absorption (Teraguchi et al.,
1998). The ability o f  L f to inhibit bacterial growth may protect the intestine of the 
newborn calf from infection, while increasing intestinal cell growth may increase both 
IgG and nutrient absorption by the intestine (Robblee et al., 2003). White (2005) saw an 
effect of L f on average apparent efficiency o f absorption (AEA), when calves were fed 
maternal colostrum with lg/d of supplemental Lf. The objective of this experiment was 
to determine the effect of various levels of L f supplementation to colostrum replacer fed 
as 1 or 2 doses on apparent efficiency of IgG absorption, serum IgG concentrations, and 
intestinal development in neonatal Holstein bull calves.
Materials and Methods 
Calves, Feeding, and Treatments
This experiment was reviewed and approved by the University of New Hampshire 
Institutional Animal Care and Use Committee (Approval # 051102).
A total o f 80 Holstein bull calves bom between March 2006 and November 2006 
at two different dairies were used. Calves were assigned randomly at birth by location to 
a 2 x 4 factorial arrangement o f treatments in a randomized complete block design.
Calves were blocked in groups o f 8 at birth by location. Randomization of treatments 
occurred within blocks. Forty-eight bull calves assigned to the experiment were bom at 
the University o f New Hampshire, Fairchild Teaching and Research Center (initial BW 
of 43.8 + 4.9 kg). Thirty-two calves were from a local New Hampshire dairy farm. All 
calves were removed from their dam and not allowed to suckle. Calves born at the 
university were weighed at birth and placed in a naturally ventilated, enclosed calf room 
in individual pens. Pens were bedded with kiln-dried sawdust. Calves born at the
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commercial dairy were not weighed at birth, as a scale was unavailable. Calves from the 
commercial dairy were placed in a naturally ventilated maternity pen and bedded with 
wheat straw. The treatment groups consisted of 1 dose1 of CR versus 2 doses of CR with 
or with/out supplemental Lf (Immucell, Portland ME). The levels of supplemental Lf 
were 0, 0.5, 1, or 2 g/d. All calves received 1 dose1 of CR with or without supplemental 
Lf within 90 min of birth. The source of Lf was bovine milk (Immucell Corp., Portland, 
ME); iron saturation was 13.2g/100g. The second feeding was at 12 h in which the calves 
received either a second dose1 of CR or 2 L of non-medicated milk replacer (MR) 
(20%CP:20%fat) with each containing the varying levels of supplemental L f depending 
on which treatment the calf was assigned. Calves continued to be fed MR with or 
without supplemental Lf in 12 h increments throughout study. Calves received 1.2% of 
its initial BW, in MR powder. The MR powder was divided into two equal portions, and 
each portion was reconstituted in 2 L of warm water immediately before feeding. At the 
sixth feeding in which calves were 60 + 2 h of age, a xylose challenge was conducted 
(university calves only) to determine xylose absorption by the small intestine. Calves 
from the commercial dairy were removed from study at 48 h, while calves bom at the 
university were removed by 72 h.
Feed Analysis
The DM of the CR and MR was determined by drying samples in the same 
forced-air convection oven at 60°C for 24 h. Samples from each bag of CR and MR were 
saved and stored at -20 °C. When the experiment was completed, samples were 
composited for nutrient analysis. Colostrum replacer and MR were analyzed for CP 
(AOAC, 1979), fatty acid (AOAC, 1995), and Ca, P, Mg, and Fe (AOAC, 1990), and Lf
1 1 dose is equal to 470g of CR reconstituted in 1L o f warm water
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after reconstituting the MR to 15% DM (RID; Cardiotech). Chemical analysis of CR and 
MR are shown in Table 1.
Blood Collections for Immunoglobulin G and Serum Protein
Blood samples were collected via jugular venipuncture before the first feeding of 
colostrum replacer (within 90 min of birth, referred to as 0 h) and at 6, 12, 18, 24, 48 h 
after birth. Samples were collected in 5-mL tubes. Samples were allowed to clot at room 
temperature for at least 1 h and then centrifuged at 3300-x g at 25°C for 20 min. Serum 
samples were stored at -20°C until analyzed for IgG by radial immunoassay (WCVM, 
Saskatoon Canada) and total serum proteins with a digital refractometer (SPER 
Scientific, model 300027 from VWR).
Blood Collections for Xylose Challenge
The xylose challenge was only performed on calves bom at the UNH Fairchild 
Dairy Teaching & Research Center. D-xylose (0.5g/kg BW) was mixed with the MR and 
fed at the sixth feeding (60 + 2 h o f age). D-xylose is used as an indirect marker for 
glucose absorption across the small intestine. Calves were fasted throughout the sampling 
period but allowed access to ad libitum water. Blood samples were taken before D- 
xylose treatment (0 h) and at 2, 4, 6, 8, and 12 h after feeding. Blood samples were 
collected into evacuated tubes via jugular venipuncture, containing tripotassium EDTA, 
to measure D-xylose and glucose concentrations in the plasma. Glucose levels were 
measured in the same blood samples to compare xylose and glucose concentrations. 
Blood samples were immediately centrifuged at 3300 x g at 5°C for 20 min to harvest 
plasma. Two aliquots of plasma were stored in 5-ml polypropylene tubes at -20°C and 
later analyzed for D-xylose and glucose concentrations. D- xylose was measured as
43
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
described by Merritt and Duelly (1983). Plasma glucose concentrations were determined 
using a glucose oxidase base kit (Wako, Richmond VA).
Measurements:
Apparent efficiency of IgG absorption (AEA) at 0, 6, 12, 18, 24 h of age was 
estimated using the equation: (plasma IgG [g/L] x body weight [kg] x 0.09/IgG intake) x 
100% (Quigley et al., 1998a). The IgG concentration, area under the curve (AUC), and 
mean IgG were analyzed. Total serum protein concentrations were also analyzed. The 
blood samples collected on d 3 at 0 ,2 , 4, 6, 8, and 12 h were analyzed for the 
concentration mean and AUC for both D-xylose and glucose.
Statistical Analysis:
A randomized complete block design with a 2 x 4 factorial arrangement of 
treatments was used, and calves were randomly assigned to treatments in blocks of eight 
based on birth order and location. Analysis of varience was conducted using the MIXED 
procedure of SAS (SAS Institute, 2001). The mixed model effect used was:
Y jjk = p + bi + Lj + Rk + LRjk + KCjjk + Ejjk 
Where:
Y = the dependent variable,
\x = the overall mean,
bj = the random effect o f block i (i = 1,...10),
Lj = the fixed effect o f the j*  lactoferrin level ( j = 0, 0.5, 1,2),
Rk = the fixed effect o f kth colostrum replacer feeding (k = 1,2),
LRjk = the fixed effect o f the interaction between the j th lactoferrin level and the kth 
colostrum replacer feeding,
K = the regression coefficient o f the covariate C
Cjjk = is the covariate variable for the 1th calf, of the ith block, of the j th lactoferrin level, 
kl colostrum replacer feeding (1 = 1,...8), and 
Ejjk is the random residual ~N(0,o2e).
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Significance was determined at a P < 0.05. Data were tested for linear, quadratic, 
and cubic response to level of Lf supplementation. Degrees o f freedom were determined 
using the Satterwaite option of the MIXED procedure of SAS (SAS® Institute, 2001).
Results
Chemical analysis of CR and MR are presented in Table 1. The Lf content of CR 
was 0.78g/dose and the lactoferrin content o f MR was 0.45 mg/g of DM.
Calves fed two doses of CR had higher mean serum IgG concentrations (P <
0.001) and total serum protein (P < 0.01) compared to calves fed one dose of CR (Table 
2). Calves fed a second dose of CR at 12 h had higher plasma IgG and total serum protein 
levels at 18, 24, and 48h, resulting in a significant feed x time interaction (P < 0.05) 
(Figure 1 and 2). On average, calves attained blood serum IgG concentration > 1 0  mg/mL 
resulting in successful passive transfer by 24 h, except for calves fed 1 dose of CR + 1 or 
2 g/d of supplemental Lf. The proportion of calves that attained passive IgG transfer per 
treatment is shown in Table 2. There were no effects of Lf supplementation on serum IgG 
concentrations and total serum protein concentrations. Area under the curve of IgG 
(Table 2) was greater for the calves fed 2 doses CR compared to the calves fed 1 dose CR 
(T O .0001). Lactoferrin supplementation had no effect on the results for AUC of IgG.
There was a decrease (P < 0.0001) in AEA of IgG when 2 doses of CR were fed 
versus 1 dose o f CR (Table 2). Apparent efficiency o f absorption of IgG decreased 
quadratically (P < 0.05) with increasing levels of L f (Table 2).
Two hours after xylose intake, plasma xylose concentrations were higher in calves 
fed two doses of CR (P < 0.01), although at 8 and 12 h after xylose intake (P<0.05) 
plasma xylose concentrations were higher in the calves fed one dose of CR (Figure 3).
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However, the overall mean for plasma xylose concentrations of all the time points’ were 
not different between calves fed one dose verses calves fed two doses o f CR (Table 2). 
Plasma xylose concentration and AUC for xylose decreased quadratically (P  <0.01) with 
increasing Lf supplementation (Table 2). There was a trend (P < 0.1) for plasma glucose 
with calves fed two doses of CR to have higher concentrations of plasma glucose then 
calves fed 1 dose of CR. There was no effect o f Lf on glucose concentrations (Table 2).
Discussion
Serum IgG concentration can be affected by dystocia (Donovan et al., 1986) and 
by birth weight, with larger calves having lower IgG concentrations on average because 
of they have higher plasma volumes (Quigley et al., 1998). In this experiment, there 
were no differences among treatments in calf birth weights or calving scores.
In this study, on average calves attained blood serum IgG concentration > 10 
mg/mL resulting in successful passive transfer by 24 h, except for calves fed 1 dose of 
CR + 1 or 2 g/d of supplemental Lf. This is different from other studies in which it was 
observed that lacteal secretion based CR did not consistently provide successful passive 
transfer (Zaremba et al., 1993; Garry et al., 1996; Mee et al., 1996; Hopkin and Quigley, 
1997; Arthington et al., 2000). However, the number of calves which attained passive 
transfer was higher when fed 2 doses of CR vs 1 dose CR (P = 0.03). The AEA of IgG 
was lower in calves fed 2 doses of CR, perhaps the result of more IgG supplied then the 
calves were able to absorb.
The purpose of adding L f to the CR was to determine if the quality of CR could 
be improved by increasing IgG absorption. A previous study conducted in our 
laboratory (White, 2005) showed an effect o f L f on average AEA over time, when bull
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calves were fed maternal colostrum with lg/d of supplemental L f  However, at 24 h only 
there was no effect o f L f on AEA of IgG. The present study showed no effect of Lf on 
serum IgG concentration but there was a suppressing quadratic effect (P<0.05) on AEA 
of IgG with increasing levels o f Lf. White (2005) added 1 g/d of L f to maternal 
colostrum, which has an average of about 2 mg/mL of Lf (Molenaar et al., 1996). The 
calves received 2 feedings (2L/feeding) of maternal colostrum bringing the total Lf 
consumed to be about 9 mg/mL. In the present study, L f was added to CR which only 
had an Lf concentration of 0.78g/dose of CR so at the highest supplementation of 2g 
these calves were still receiving less Lf then the calves used by White (2005). In addition, 
maternal colostrum may have other nutrients such as vitamins and other bioactive 
proteins that may aid in IgG absorption and intestinal development that may not be 
present in the CR.
The decrease in AEA of IgG when L f was supplemented to CR may have been 
caused by L f ability to bind to Ig such as IgG and IgA prior to absorption(Wang and 
Hurley, 1998). This would increase the overall size of the molecule, thus possibly 
decreasing it ability to be absorbed. Other components found in maternal colostrum may 
compensate for this effect, resulting in Lf not hindering IgG absorption as shown by 
White (2005). The complexes between Lf and other proteins may either enhance or 
reduce its biological functions (Wang and Hurley, 1998). In the case o f Lf binding to 
IgA, there is a synergistic effect on bacteriostatic activity (Stephans et al., 1980) but the 
Lf-casein complex decreases the antibacterial activity of L f (Ellison and Giehl, 1991; 
Hurley, 1993).
47
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
There was a decreasing quadratic effect (PO .O l) with increasing Lf 
supplementation on xylose absorption and AUC with calves fed 0.5 and lg  of Lf having 
lower plasma xylose concentration than calves fed 0 and 2 g o f Lf. The xylose absorption 
test is used as an indirect measurement of glucose absorption, intestinal epithelial size 
and function (Hammon and Blum, 1997; Kuhne et al., 2000; Rauprich et al., 2000). The 
results from this study indicate that L f is impairing xylose absorption and possibly 
intestinal development when supplemented at 0.5 and 1 g per day for the first 3 days of 
life. Cowles et al. (2006) also performed a xylose challenge on calves fed MR 
supplemented with 1 g/d of L f and found no effect of Lf. However, calves were 10 days 
old at the time of the xylose challenge and only fed one level o f L f at lg/d added to either 
a nonmedicated conventional MR (20% CP: 20% fat) or a nonmedicated intensified MR 
(28% CP:20% fat). These authors reported no effect of feeding the lg/d of Lf on xylose 
absorption while in the present study both 0.5 and lg/d of Lf had a negative impact on 
xylose absorption. The maximum Lf fed per feeding was 1.78 mg/mL in the present 
study compared to Cowles et al. (2006) in which the maximum Lf fed per feeding was 
1.05 mg/mL.
This is contradictory to other studies in which Lf was observed to increase 
intestinal development (Zhang et al., 2001; Humphrey et al., 2002). However, Zhang et 
al. (2001) fed milk from transgenic dams to neonatal mice for 10 d. The milk from these 
transgenic dams had a L f concentration of 12 mg/mL. Zhang et al. (2001) fed Lf at a 
much higher concentration and for a longer period of time than in the current study. 
Humphrey et al. (2002) observed greater villous height, better nutrient absorption, and 
greater feed efficiency in chicks when L f was fed in combination with lysozyme. There
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wasjno effect on intestinal development when Lf was fed alone. These studies would 
indicate that if  the neonatal calf responded in the same way as neonatal mice and chicks 
than Lf would have to be fed at a much higher concentration or in conjunction with 
another component o f maternal colostrum such as lysozyme.
Conclusion
Calves can attain successful passive transfer when fed 1 dose of a lacteal based 
CR. However, feeding calves 2 doses of CR is recommended to provide a margin of 
safety due to factors affecting absorption. The AEA of IgG in CR is not improved by 
Lf supplementation at the levels fed. Lactoferrin does not increase xylose absorption 
in the calf at the levels fed; suggesting intestinal development is not improved by Lf 
supplementation. More research needs to be done to determine the components in 
maternal bovine colostrum that affect intestinal development and IgG absorption.
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Tablel. Nutrient analysis on a DM basis of Colostrum Replacer and 
Milk Replacer______________________ __________________________
Item CR1 MR2
DM, % 93.5 89.5
CP, % 54.9 20.6
Fat ( acid hydrolysis),% 22.6 18.9
Ca, % 1.1 0.97
P, % 0.99 0.64
Mg, % 0.16 0.15
Fe, ppm 102
Lactoferrin (g/dose3) 0.78g/dose 0.48mg/g
Land O Lakes colostrum replacer, Saskatoon, SK, Canada 
2 Blue Seal Feeds non-medicated milk replacer, Londonderry, NH 
3 1 dose is equal to 470 g with > lOOg of bovine IgG
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Table 2: Overall means of IgG, serum protein, xylose and glucose. Apparent efficiency of absorption of IgG and area under the curve for IgG, 
xylose, and glucose.______________________________________________________________________________________________ _______
Item
1 CR2
T r e a tm en ts1
2 CR
Lactoferrin C on trasts3
0 0.5 1 2 0 0.5 1 2 SE CR Effect4 Linear Quadratic
SPT, % 0.8 0.79 0.7 0.4 0.9 0.79 0.9 0.9 0.13 0.03 NS6 NS
Serum, IgG7 g/L
Avg. 9.7 9.0 8.8 8.1 11.2 10.3 11.3 10.8 0.64 < 0.001 NS NS
24-h 10.7 10.3 9.7 8.7 14.5 13.1 14.5 14.1 1.00 < 0.001 NS NS
Serum Protein7 (g/L)
Avg. 4.9 4.8 4.9 4.8 5 5.1 4.9 5.1 0.10 < 0.001 NS NS
24-h 4.9 4.7 5.0 4.6 5.4 5.4 5.3 5.5 0.14 < 0.001 NS NS
AUC lgG7(g/L'h) 2160.1 1875.9 1827.4 1442.9 3306.2 2449.9 3459.5 3099.8 370.9 < 0.0001 NS NS
AEA8, % 44.0 41.0 34.0 39.0 33.0 26.0 28.0 29.0 2.99 < 0.0001 NS 0.03
Xylose8 (mmol/L) 2.1 1.8 1.9 2.0 2.0 1.8 1.9 2.0 0.09 NS NS 0.002
AUC Xylose8 (mmol/dL-h) 31.3 24.3 26.9 26.7 29.3 22.3 24.6 28.2 1.9 NS NS 0.004
Glucose8 (mg/dL) 103.9 100 95.8 96.9 103.5 106.6 104.7 99.5 3.49 0.07 NS NS
AUC Glucose8 (mg/dLh) 66989.0 62349.0 57835.0 59067.0 66586.0 70293.0 67823.0 61614.0 5457.0 NS NS NS
Calves were fed either 1 dose of CR or 2 doses of CR with either 0, 0.5, 1, or 2 g/d of lactoferrin in the first two feedings. 
2CR = colostrum replacer
3Contrast: linear and quadratic effects of lactoferrin.
4 Main effect of colostrum replacer.
5 SPT = Proportion o calves that attained successful passive IgG transfer > 10g/L 
6P<0.05.
7 Data collected from all 80 calves collected from both dairies.
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Figure 1: Serum IgG concentrations (mg/mL) o f calves fed either I or 2 doses of CR with varying levels of lactoferrin over the first 
48h of life. 1L0 = 1 dose CR + Og of lactoferrin, 1L0.5 = 1 dose CR + 0.5g of lactoferrin, 1L1 = 1 dose CR + lg of lactoferrin, 1L2 = 
1 dose CR + 2g of lactoferrin, 2L0 = 2 dose CR + Og of lactoferrin, 2L0.5 = 2 dose CR + 0.5g of lactoferrin, 2L1 = 2dose CR + lg  o f 
lactoferrin, 2L2 = 2 dose CR + 2g of lactoferrin. The largest SEM was 0.87 and occurred in calves fed 1L2 for all time points.
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Figure 2: Serum Protein concentration (mg/mL) of calves fed either 1 or 2 doses o f CR with varying levels o f lactoferrin over the first 
48h of life. 1L0 = 1 dose CR + Og of lactoferrin, 1L0.5 = 1 dose CR + 0.5g o f lactoferrin, 1L1 = 1 dose CR + lg  o f lactoferrin, 1L2 =
1 dose CR + 2g of lactoferrin, 2L0 = 2 dose CR + Og of lactoferrin, 2L0.5 = 2 dose CR + 0.5g of lactoferrin, 2L1 = 2dose CR + lg of 
lactoferrin, 2L2 = 2 dose CR + 2g o f lactoferrin. The largest SEM was 0.13 and occurred in calves fed 1L2 for all time points.
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Figure 3: Plasma xylose concentration (mg/mL) of calves fed either 1 or 2 doses o f CR with varying levels of lactoferrin over the first 
48h of life. 1L0 = 1 dose CR + Og o f lactoferrin, 1L0.5 = 1 dose CR + 0.5g of lactoferrin, 1L1 = 1 dose CR + lg  of lactoferrin, 1L2 =
1 dose CR + 2g of lactoferrin, 2L0 = 2 dose CR + Og of lactoferrin, 2L0.5 = 2 dose CR + 0.5g o f lactoferrin, 2L1 = 2dose CR + lg o f 
lactoferrin, 2L2 = 2 dose CR + 2g of lactoferrin. The largest SEM was 0.15 and occurred in calves fed 1L1 for all time points.
* (P <0.01) Calves fed two doses of CR had higher plasma xylose concentrations and a quadratic response to lactoferrin with 0.5g/d 
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Figure 4: Plasma glucose concentration (mg/mL) of calves fed either 1 or 2 doses of CR with varying levels o f lactoferrin over the 
first 48h of life. 1L0 = 1 dose CR + Og o f lactoferrin, 1L0.5 = 1 dose CR + 0.5g o f lactoferrin, 1L1 = 1 dose CR + lg  of lactoferrin, 
1L2 = 1 dose CR + 2g of lactoferrin, 2L0 = 2 dose CR + Og of lactoferrin, 2L0.5 = 2 dose CR + 0.5g of lactoferrin, 2L1 = 2dose CR + 
lg  of lactoferrin, 2L2 = 2 dose CR + 2g of lactoferrin. The largest SEM was 5.12 occurring at all time points.
* (P <0.05) Calves fed two doses of CR had greater glucose concentrations.
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